Gamida-Cell, which is active in the field of blood stem cell expansion to treat disease, has raised $20 million to date. Batya Feldman 5 Feb 04 16:54 Israeli start-up Gamida-Cell has been chosen to receive the “Best Abstracts Award” by the American Society for Blood and Marrow Transplantation. The award will be presented to the Gamida-Cell research team on February 13th in Orlando, Florida. Gamida-Cell is active in the field of blood stem cell expansion for cancer and autoimmune disease therapies.
Source: http://www.globes.co.il/serveen/globes/docview.asp?did=768660%26fid=942
[Editor: The preceding article was not written by A4M/WHN]
